This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2WB Kannel (2002) Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 11, 101–107.
3W de Ruijter , RGJ Westendorp , WJJ Assendelft , (2009) Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338, a3083.
5P Verhoef , MJ Stampfer , JE Buring , (1996) Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 143, 845–859.
6O Nygard , JE Nordrehaug , H Refsum , (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337, 230–236.
7Homocysteine-Lowering Triallists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 316, 894–898.
8AG Bostom , H Silbershatz , IH Rosenberg , (1999) Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159, 1077–1080.
9JD Kark , J Selhub , B Adler , (1999) Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 131, 321–330.
10P Whincup , H Refsum , I Perry , (1999) Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart 82, 448–454.
11JL Anderson , JB Muhlestein , BD Horne , (2000) Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102, 1227–1232.
12T Omland , A Samuelsson , M Hartford , (2000) Serum homocysteine as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med 160, 1834–1840.
15J Blacher , A Benetos , JM Kirzin , (2002) Relation of plasma total homocysteine to cardiovascular mortality in a French population. Am J Cardiol 90, 591–595.
16DE Zylberstein , C Bengtsson , C Bjorkelund , (2004) Serum homocysteine in relation to morbidity and mortality from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg. Circulation 109, 601–606.
17JK Virtanen , S Voutilainen , G Alfthan , (2005) Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors. J Intern Med 257, 255–262.
18V Menon , MJ Sarnak , T Greene , (2006) Relationship between homocysteine and mortality in chronic kidney disease. Circulation 113, 1572–1577.
20GP Rossi , G Maiolino , TM Seccia , (2006) Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. J Hypertens 24, 851–859.
24M Mansoor , A Svardal & P Ueland (1992) Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in human plasma. Anal Biochem 200, 218–229.
25CJ Bates , KD Pentieva , N Matthews , (1999) A simple, sensitive and reproducible assay for pyridoxal phosphate in human plasma. Clin Chim Acta 280, 101–111.
27J Danesh , JG Wheeler , GM Hirschfield , (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350, 1387–1397.
29M Haim , D Tanne , U Goldbourt , (2006) Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease. Cardiology 107, 52–56.
31CJ Bates , MA Mansoor , JC van der Pols , (1998) Plasma total homocysteine in 972 British men and women aged 65 years and over. Eur J Clin Nutr 51, 691–697.
32CJ Bates , KD Pentieva & A Prentice (1999) An appraisal of vitamin B6 status indices and associated confounders, in young people aged 4–18 years and in people aged 65 years and over, in two national British surveys. Public Health Nutr 2, 529–535.
34Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288, 2015–2022.
35DS Wald , M Law & JK Morris (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202–1206.
36M Cesari , G Onder , V Zamboni , (2009) C-reactive protein and lipid parameters in older persons aged 80 years and older. J Nutr Health Aging 13, 587–593.
37B Zethelius , L Berglund , J Sundström , (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358, 2107–2116.
38CJ Bates , MEJ Lean , MA Mansoor , (2004) Nutrient intakes: biochemical and risk indices associated with type 2 diabetes and glycosylated haemoglobin, in the British National Diet and Nutrition Survey of people aged 65 years and over. Diabet Med 21, 677–684.
39M Chonchol , R Katz , LF Fried , (2010) Glycosylated hemoglobin and the risk of death and cardiovascular mortality in the elderly. Nutr Metab Cardiovasc Dis 20, 15–21.
41JK Virtanen , S Voutilainen , TH Rissanen , (2005) High dietary methionine intake increases the risk of acute coronary events in middle-aged men. Nutr Metab Cardiovasc Dis 16, 113–120.